Optic Inc
- Biotech or pharma, therapeutic R&D
- Other R&D services
Pharma-trained AI Co-Pilot to Uncover, Validate, Invest.
OPTIC is a San Francisco–based, AI-powered tech-bio company backed by KPCB and Greylock. Our flagship BIOPTIC® platform equips life-science investors and pharma partners with modular, agentic AI trained on real-world cash-flow, valuation and pipeline data to find and evaluate undervalued drug assets and direct idle capital into high-value opportunities.
BIOPTIC can supercharge asset scouting, scale due diligence, and bridge the capital-allocation gap - linking cash-rich investors with undervalued drug candidates before the window of opportunity closes. Our pharma-smart AI agents can automate every step - from discovery to in-licensing - by parsing billions of data points in minutes, assessing risk-reward profiles, and delivering a ready-to-execute deal flow directly to your BD team.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}